Did you mean: David Dobrzynski
[HTML][HTML] Heterologous SARS-CoV-2 booster vaccinations–preliminary report
…, TM Babu, K Rajakumar, S Edupuganti, D Dobryzynski… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective,
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
[HTML][HTML] Homologous and heterologous Covid-19 booster vaccinations
…, S Edupuganti, D Dobrzynski… - … England Journal of …, 2022 - Mass Medical Soc
Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …
have received emergency use authorization in the United States are highly effective, …
[PDF][PDF] Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
…, K Rajakumar, S Edupuganti, D Dobrzynski… - Cell Reports …, 2022 - cell.com
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
[HTML][HTML] Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
…, M Bäcker, AC Kottkamp, TM Babu, D Dobrzynski… - npj Vaccines, 2023 - nature.com
As part of a multicenter study evaluating homologous and heterologous COVID-19 booster
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …
Antibiotic use and associated risk factors for antibiotic prescribing in COVID-19 hospitalized patients
AJ Martin, S Shulder, D Dobrzynski… - Journal of …, 2023 - journals.sagepub.com
Background: Literature suggests that antibiotic prescribing in COVID-19 patients is high.
Currently, there are insufficient data on what drives antibiotic prescribing practices throughout …
Currently, there are insufficient data on what drives antibiotic prescribing practices throughout …
Thrombin activity of fibrin thrombi and soluble plasmic derivatives
…, GH Barlow, TM Florack, DM Dobrzynski… - The Journal of …, 1983 - translationalres.com
Fibrin was prepared from purified fibrinogen, plasma, and pathologic arterial thrombi and
assayed for thrombin activity. Activity was detected on fibrin from each of these sources when …
assayed for thrombin activity. Activity was detected on fibrin from each of these sources when …
Epidemiology of gram-negative bloodstream infections in the United States: results from a cohort of 24 hospitals
…, SE Cosgrove, D Dobrzynski… - Open forum …, 2023 - academic.oup.com
Background To address knowledge gaps in management of Gram-negative bloodstream
infection, the Antibiotic Stewardship Implementation Collaborative was established consisting …
infection, the Antibiotic Stewardship Implementation Collaborative was established consisting …
Hospital readmissions after laboratory-confirmed influenza hospitalization
DM Dobrzynski Jr, DN Ndi, Y Zhu… - The Journal of …, 2020 - academic.oup.com
Background Influenza infection causes substantial morbidity and mortality. However, little is
known about hospital readmissions after an influenza hospitalization. The aim of our study …
known about hospital readmissions after an influenza hospitalization. The aim of our study …
Clinical Outcomes and Treatment Strategies in Patients with Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible …
…, KE Pillinger, AJ Martin, D Dobrzynski… - Annals of …, 2023 - journals.sagepub.com
Background: Carbapenem-resistant Enterobacterales (CRE) are difficult to treat and can
cause significant morbidity and mortality, however most data reflect carbapenemase-producing …
cause significant morbidity and mortality, however most data reflect carbapenemase-producing …
SARS-CoV-2 Omicron neutralization after heterologous vaccine boosting
…, TM Babu, K Rajakumar, S Edupuganti, D Dobrzynski… - medRxiv, 2022 - medrxiv.org
As part of an ongoing study assessing homologous and heterologous booster vaccines,
following primary EUA series, we assessed neutralization of D614G and Omicron variants prior …
following primary EUA series, we assessed neutralization of D614G and Omicron variants prior …
Did you mean to search for: David Dobrzynski